|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61P 35/02 | (2006.01) |
| (11) | Number of the document | 2658870 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11810777.0 |
| Date of filing the European patent application | 2011-12-30 | |
| (97) | Date of publication of the European application | 2013-11-06 |
| (45) | Date of publication and mention of the grant of the patent | 2018-04-25 |
| (46) | Date of publication of the claims translation | 2018-09-10 |
| (86) | Number | PCT/US2011/068244 |
| Date | 2011-12-30 |
| (87) | Number | WO 2012/092616 |
| Date | 2012-07-05 |
| (30) | Number | Date | Country code |
| 201161470382 P | 2011-03-31 | US | |
| 201061428699 P | 2010-12-30 | US | |
| 201161470406 P | 2011-03-31 | US | |
| 201161485104 P | 2011-05-11 | US |
| (72) |
ELIAS, Kathleen, Ann, US
LANDES, Gregory, US
SINGH, Shweta, US
KORVER, Wouter, US
DRAKE, Andrew, Walling, US
HAAK-FRENDSCHO, Mary, US
SNELL, Gyorgy, Pal, US
BHASKAR, Vinay, US
|
| (73) |
Takeda Pharmaceutical Company Limited,
1-1 Doshomachi 4-chome Chuo-ku, Osaka-shi, Osaka 541-0045,
JP
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Konjuguoti anti-CD38 antikūnai |
| CONJUGATED ANTI-CD38 ANTIBODIES |
| Payment date | Validity (years) | Amount | |
| 2024-11-21 | 14 | 289.00 EUR |
| 2025-12-30 |